BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • Monitoring the spread of Chronic Kidney Disease morbidity in cooperation with biospecimen research organizations

Monitoring the spread of Chronic Kidney Disease morbidity in cooperation with biospecimen research organizations

Monitoring the spread of Chronic Kidney Disease morbidity in cooperation with biospecimen research organizations

02.08.2022
Chronic Kidney Disease biospecimens collection for your research by BIOMEDICA CRO
admin2024-05-29T14:39:28+00:00

Researchers examined sex differences in the prevalence and development of CKD – a study review by the BIOMEDICA CRO team

Chronic Kidney Disease (CKD) affects about 10% of the population annually. Scientists from Karolinska Institutet in Sweden discovered that women with reduced kidney function received a diagnosis of CKD less than men in the same situation.

“Our results clearly show sex differences in the care of Chronic Kidney Disease that disadvantage women. We believe that efforts to improve the situation and ensure equal care can reduce both society’s and the individual’s burden of this disease”, – Juan Jesus Carrero, study’s last author, professor at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.

Researchers recruited over 220,000 people 18+ years identified when they first exhibited reduced kidney function with a so-called eGFR value below 60 ml/min/1.73m2.
In 91 percent of the men and 87 percent of the women, kidney function had been monitored by additional creatinine measurement at least once over the subsequent 18 months. The numbers for the measurement of albumin in the urine were lower: 34 percent and 28 percent, respectively. The differences between men and women were attenuated but remained when the researchers adjusted for comorbidities, medications or educational level and were also noticed among people with confirmed Chronic Kidney Disease after repeated testing.

Mentioned above results bring attention to a problem amenable to correction, and this should be the next focus.

Please find more information in the Journal of the American Society of Nephrology, “Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study”.

Chronic Kidney Disease biospecimens collection for your research by BIOMEDICA CRO

BIOMEDICA CRO has provided prospective and retrospective collections of the numerous human biospecimen types and associated clinical data since 2017.

We built a strong base of clinical sites with 50+ contracted hospitals in various disease areas. The access to nephrology departments allows us to provide biospecimens from donors with Chronic Kidney Disease for your research.

It is feasible to collect the following specimens from this cohort:

  • Whole blood;
  • Single/double spun plasma;
  • Serum;
  • Buffy coat;
  • PBMCs;
  • Urine;
  • Stool;
  • Saliva, etc.

In addition to human biospecimens, we can obtain precise clinical data, laboratory test results and other valuable information from each donor.

Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn. Our professional team is ready to join new projects and contribute to scientific cooperation!

Feel free to place a request for human biospecimens.

Share this post

Facebook Twitter LinkedIn
All publications
BIOMEDICA CRO – 5 years of being your global biospecimen partner
Cardiovascular diseases research: from supplying biospecimens to discovering new drugs
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.